USRE23702E - L-carbalkoxy-x-substituted - Google Patents
L-carbalkoxy-x-substituted Download PDFInfo
- Publication number
- USRE23702E USRE23702E US23702DE USRE23702E US RE23702 E USRE23702 E US RE23702E US 23702D E US23702D E US 23702DE US RE23702 E USRE23702 E US RE23702E
- Authority
- US
- United States
- Prior art keywords
- parts
- carbethoxy
- solution
- reaction
- trans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- -1 aliphatic alcohols Chemical class 0.000 description 5
- VVZAIGZNZMZDFX-SFYZADRCSA-N ethyl (2S,5R)-2,5-dimethylpiperazine-1-carboxylate Chemical compound CCOC(=O)N1C[C@@H](C)NC[C@@H]1C VVZAIGZNZMZDFX-SFYZADRCSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 239000011593 sulfur Substances 0.000 description 5
- ZNNZYHKDIALBAK-UHFFFAOYSA-M Potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229940011051 isopropyl acetate Drugs 0.000 description 4
- GWYFCOCPABKNJV-UHFFFAOYSA-M isovalerate Chemical compound CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 4
- 150000004885 piperazines Chemical class 0.000 description 4
- 229940116357 potassium thiocyanate Drugs 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- GKKCIDNWFBPDBW-UHFFFAOYSA-M Potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N Carbon tetrachloride Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- IQFVPQOLBLOTPF-HKXUKFGYSA-L Congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N Ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000002378 acidificating Effects 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000005712 crystallization Effects 0.000 description 2
- 230000001419 dependent Effects 0.000 description 2
- SSNMQYMVJCCSHM-UHFFFAOYSA-N ethyl 4-carbamothioylpiperazine-1-carboxylate Chemical compound CCOC(=O)N1CCN(C(N)=S)CC1 SSNMQYMVJCCSHM-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NSMWYRLQHIXVAP-OLQVQODUSA-N (2R,5S)-2,5-dimethylpiperazine Chemical compound C[C@H]1CN[C@H](C)CN1 NSMWYRLQHIXVAP-OLQVQODUSA-N 0.000 description 1
- KHXVMPOQLJDTLN-UHFFFAOYSA-N C(=O)(OCC)N1C(CN(C(C1)C)C(N)=N)C Chemical compound C(=O)(OCC)N1C(CN(C(C1)C)C(N)=N)C KHXVMPOQLJDTLN-UHFFFAOYSA-N 0.000 description 1
- ZCYXTTSVVTVZBC-SFYZADRCSA-N C(=O)(OCC)N1[C@H](CN([C@@H](C1)C)C(N)=S)C Chemical compound C(=O)(OCC)N1[C@H](CN([C@@H](C1)C)C(N)=S)C ZCYXTTSVVTVZBC-SFYZADRCSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZATMHSXKYYALKR-WLYNEOFISA-N Cl.C(=O)(OCC)N1[C@H](CN[C@@H](C1)C)C Chemical compound Cl.C(=O)(OCC)N1[C@H](CN[C@@H](C1)C)C ZATMHSXKYYALKR-WLYNEOFISA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N Ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- ZBKFYXZXZJPWNQ-UHFFFAOYSA-N [N-]=C=S Chemical compound [N-]=C=S ZBKFYXZXZJPWNQ-UHFFFAOYSA-N 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 239000002501 antifilarial agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000020127 ayran Nutrition 0.000 description 1
- 238000010533 azeotropic distillation Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- XZMCDFZZKTWFGF-UHFFFAOYSA-N carbodiimide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- XAZYMMNOLTYSFQ-UHFFFAOYSA-N ethyl 4-carbamoylpiperazine-1-carboxylate Chemical compound CCOC(=O)N1CCN(C(N)=O)CC1 XAZYMMNOLTYSFQ-UHFFFAOYSA-N 0.000 description 1
- HBNYJWAFDZLWRS-UHFFFAOYSA-N ethyl isothiocyanate Chemical compound CCN=C=S HBNYJWAFDZLWRS-UHFFFAOYSA-N 0.000 description 1
- SLKWSZYSOUHYME-UHFFFAOYSA-N ethyl piperazine-1-carboxylate;hydrochloride Chemical compound Cl.CCOC(=O)N1CCNCC1 SLKWSZYSOUHYME-UHFFFAOYSA-N 0.000 description 1
- 201000006353 filariasis Diseases 0.000 description 1
- 238000007499 fusion processing Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- NNBBQNFHCVVQHZ-UHFFFAOYSA-N methyl carbamimidothioate;sulfuric acid Chemical compound CSC(N)=N.OS(O)(=O)=O NNBBQNFHCVVQHZ-UHFFFAOYSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
Definitions
- This invention relates to new organic com pounds and their preparation. More particularly it relates to 1carbalkoxy-i-substituted piperazines.
- R and R are members of the group consisting of hydrogen and lower alkyl radicals
- R" and R"" are hydrogen and aliphatic radicals
- X is a member of the group consisting of oxygen, sulfur, and imino radicals.
- lower alkyl radical means a radical of 1 to 4 carbon atoms.
- the compounds of the present invention are solids, white to tan in color. In some cases the compounds may take the form of an oil.
- the compounds are in general slightly soluble in water but readily soluble in benzene, lower aliphatic alcohols, isopropyl acetate and the like. Where X is the imino radical, water soluble addition salts may be formed.
- R and R are as previously defined or addition salts of such piperazines with any com.- pound which is capable. of introducing into the 4-position of the piperazine nucleus a group represented by 2 city-3,5-dimethylpiperazine, and the like.
- an acid binding substance such as an alkali metal bicarbonate, alkali metal carbonate, or the like.
- the guanyl derivatives of l-carbalkoxypiperazines may be prepared by two methods; (1) by the reaction of a l-carbalkoxypiperazine salt with a cyanamide, and (2) by the reaction of a l-carbalkoxypiperazine with an S-alkylisothiourea salt.
- a suitable solvent in carrying out either process is water or aqueous alcohol.
- the reaction in. general, is, preferably carried out in solution, although it can be carried out as a fusion process. Temperatures of 20 to 110 C. are usually suflicient to complete the reaction in a reasonable time when water is used as the solvent. Generally, the reaction is carried out at 20 to about 80 C. when aqueous alcoholic solvents or hydrocarbon solvents, such as benzene, are used. The conditions under which the reaction is carried out are dependent both upon the group being introduced into. the. 4-position and upon the reactivity of the l-carbalkoxypiperazine. [For instance, l-carbethoxypiperazine hydrochloride can be treated in aqueous solution.
- Example 1 [To a solution of 19.4 parts of l-carbethoxypiperazine in parts of water is added 9.7 parts of potassium thiocyanate, and the reaction mixture is allowed to stand for about four hours. It is then evaporated under reduced pressure to a viscous residue. On the addition of 16 parts of absolute ethyl alcohol to the residue, a white solid forms. This solid is separated by filtration and the ethanol filtrate is then evaporated. On chilling, a solid residue is obtained. The solid is further purified by recrystallization from isopropyl acetate. The product, l-carbethoxylthiocarbamylpiperazine, melts at 109.0110.5 0.]
- Example 2 A solution of 82 parts of potassium cyanate in '75 parts of water is added to a solution of 195 parts of 1-carbethoxypiperazine hydrochloride in 125 parts of water. After standing at room temperature for twenty-four hours, the mixture is evaporated to dryness. The residue is extracted with 400 parts of absolute ethanol, acidified with hydrochloric acid and then it is evaporated to about 125 parts of ethanol. On cooling, the product crystallizes from solution. The precipitate, after isolation, is further purified by recrystallization from ethanol using activated charcoal. A yield of 146 parts of 1-carbethoxy-4-carbamylpiperazine, melting at 161162 0., is obtained.
- Example 3 To a solution of 63.3 parts of l-carbethoxypiperazine in 175 parts of benzene there is slowly added at -40 0., with cooling and stirring, 34.8 parts of ethyl isothiocyanate. The mixture is stirred at refluxing temperature for one-half hour. The benzene solution is concentrated and the product is precipitated by the addition of petroleum ether. On recrystallization from a mixture of isopropyl acetate and petroleum ether, the product, 1-carbethoxy-4-ethylthiocarbamylpiper-azine, melting at 9191.5 0., is obtained.
- Example 4 To a solution of 56 parts of trans-l-carbethoxy- 2,5-dimethylpiperazine in parts of water is added concentrated hydrochloric acid until the solution is slightly acidic to Congo red paper. Then 24.3 parts of solid potassium cyanate is added and the mixture is stirred until all the potassium cyanate dissolves. After standing, for twenty-four hours, the product is separated by filtration. On crystallization from carbon tetrachloride, the product, trans-1-carbethoxy-4-carbamy1-2,5-dimethylpiperazine, melting at 118.5- 119.5 0., is obtained.
- the intermediate, trans-1-carbethoxy-2,5-dimethylpiperazine may be prepared from ethyl chlorocarbonate and trans2,5dimethylpiperazine by the method described by Moore, Boyle and Thorn, Journal of the Chemical Society, 39 (1929). It distills at 112 at 10 mm.
- Example 6 To a solution of 78 parts of ethyl alcohol in parts of Water are added 41.8 parts of S- methylisothiourea sulfate and 56 parts of trans- 1-carbethoxy-2,5dimethylpiperazine. The reaction mixture is refluxed on a steam bath until The reaction mixture is dehydrated by azeotropic distillation with benzene. The resulting solid, trans- 1-carbethoxy-2,5-dimethyl 4 guanylpiperazine sulfate, may be further purified by crystallization in the usual manner.
- Example 7 N N H N-00Oalky1 wherein R and R are members of the group consisting of hydrogen and lower alkyl radicals, R and R are members of the group consisting of hydrogen and alkyl radicals, and X is a member of the group consisting of oxygen, sulfur and imino radicals, and R" and R' are not simultaneously hydrogen when X is sulfur.
- R" and R' are members of the group consisting of hydrogen and alkyl radicals
- X is a member of the group consisting of oxygen, sulfur and imino radicals, and R and R are not simultaneously hydrogen when X is sulfur.
- a 1-carbalkoxy-4 -dialkylthiocarbamylpiperazine having the general formula:
- R" and R are alkyl radicals.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
' Reissued Aug. 18, 1953 UNITED STATES PATENT OFFICE 1- CARBALKOXY- 4- SUBSTITUTED PIPERAZINES No' Drawing. Original No. 2,535,971, dated December 26, 1950, Serial No. 54,816, October 15,
1952, Serial No. 329,153
5 Claims.
Application for reissue December 31,
Matter enclosed in heavy brackets appears in the original patent but forms no part ofthis reissue specification; matter printed in italics indicates the additions made by reissue.
This invention relates to new organic com pounds and their preparation. More particularly it relates to 1carbalkoxy-i-substituted piperazines.
The l-carbalkoxypiperazines of the present in- .vention may be illustrated by the following general formula:
wherein R and R are members of the group consisting of hydrogen and lower alkyl radicals, R" and R""are hydrogen and aliphatic radicals and X is a member of the group consisting of oxygen, sulfur, and imino radicals. As used herein, the term "lower alkyl radical means a radical of 1 to 4 carbon atoms.
In general, the compounds of the present invention are solids, white to tan in color. In some cases the compounds may take the form of an oil. The compounds are in general slightly soluble in water but readily soluble in benzene, lower aliphatic alcohols, isopropyl acetate and the like. Where X is the imino radical, water soluble addition salts may be formed.
The preparation of the newcompound's of the present invention may be accomplished in several ways dependent to a large extent on the nature of'the' product desired. We preferto prepare the compounds by reacting al-carbalkoxypiperazine having the formula:
wherein R and R are as previously defined or addition salts of such piperazines with any com.- pound which is capable. of introducing into the 4-position of the piperazine nucleus a group represented by 2 city-3,5-dimethylpiperazine, and the like. In a reaction of this type wherein a halogen acid is liberated, it is usually desirable to have present an acid binding substance such as an alkali metal bicarbonate, alkali metal carbonate, or the like.
As intermediates to be reacted with the 1- carbalkoxypiperazines, we can use an alkali metal cyanate or a monoor dialkylcarbamyl chloride to. produce the l-carbalkoxy-4-carbamylpiperazines. In producing l-carbalkoxyi-thiocarbamylpiperazines, we can use as intermediates [an alkali metal thiocyanate,] an aliphatic isothiocyanate or a monoor dialkylthiocarbamyl chloride. The guanyl derivatives of l-carbalkoxypiperazines may be prepared by two methods; (1) by the reaction of a l-carbalkoxypiperazine salt with a cyanamide, and (2) by the reaction of a l-carbalkoxypiperazine with an S-alkylisothiourea salt. A suitable solvent in carrying out either process is water or aqueous alcohol.
The reaction, in. general, is, preferably carried out in solution, although it can be carried out as a fusion process. Temperatures of 20 to 110 C. are usually suflicient to complete the reaction in a reasonable time when water is used as the solvent. Generally, the reaction is carried out at 20 to about 80 C. when aqueous alcoholic solvents or hydrocarbon solvents, such as benzene, are used. The conditions under which the reaction is carried out are dependent both upon the group being introduced into. the. 4-position and upon the reactivity of the l-carbalkoxypiperazine. [For instance, l-carbethoxypiperazine hydrochloride can be treated in aqueous solution. with potassium thiocyanate at room temperature togive 1-carbethoxy-4-thiocarbamylpiperazine; when trans-l-carbethoxy-2,5-dimethylpiperazine. hydrochloride is treatedv under similar conditions, no appreciable amount of trans 1 carbethoxy 4 thiocarbamyl 2,5-dimethylpiperazine is produced. The latter may be obtained, however, by the heating of trans-1- carbethoxy-2,5-dimethylpiperazine hydrochloride without an added solvent in the presencev of potassium thiocyanate to the iusionpoint of the mixture] Some of the compounds in the present application are active antifilarial agents and may be useful in the treatment of filariasis. Other compounds produce sedation in animals stimulated with an agent such as ephedrine, and still other compounds show analgesic activity. In general, the compounds are characterized by their relatively lowtoxicity.
The following examples show in greater detail 3 c the preparation of illustrative l-carbalkoxylsubstituted piperazines within the scope of the present invention.
[Example 1] [To a solution of 19.4 parts of l-carbethoxypiperazine in parts of water is added 9.7 parts of potassium thiocyanate, and the reaction mixture is allowed to stand for about four hours. It is then evaporated under reduced pressure to a viscous residue. On the addition of 16 parts of absolute ethyl alcohol to the residue, a white solid forms. This solid is separated by filtration and the ethanol filtrate is then evaporated. On chilling, a solid residue is obtained. The solid is further purified by recrystallization from isopropyl acetate. The product, l-carbethoxylthiocarbamylpiperazine, melts at 109.0110.5 0.]
Example 2 A solution of 82 parts of potassium cyanate in '75 parts of water is added to a solution of 195 parts of 1-carbethoxypiperazine hydrochloride in 125 parts of water. After standing at room temperature for twenty-four hours, the mixture is evaporated to dryness. The residue is extracted with 400 parts of absolute ethanol, acidified with hydrochloric acid and then it is evaporated to about 125 parts of ethanol. On cooling, the product crystallizes from solution. The precipitate, after isolation, is further purified by recrystallization from ethanol using activated charcoal. A yield of 146 parts of 1-carbethoxy-4-carbamylpiperazine, melting at 161162 0., is obtained.
Example 3 To a solution of 63.3 parts of l-carbethoxypiperazine in 175 parts of benzene there is slowly added at -40 0., with cooling and stirring, 34.8 parts of ethyl isothiocyanate. The mixture is stirred at refluxing temperature for one-half hour. The benzene solution is concentrated and the product is precipitated by the addition of petroleum ether. On recrystallization from a mixture of isopropyl acetate and petroleum ether, the product, 1-carbethoxy-4-ethylthiocarbamylpiper-azine, melting at 9191.5 0., is obtained.
Example 4 To a solution of 56 parts of trans-l-carbethoxy- 2,5-dimethylpiperazine in parts of water is added concentrated hydrochloric acid until the solution is slightly acidic to Congo red paper. Then 24.3 parts of solid potassium cyanate is added and the mixture is stirred until all the potassium cyanate dissolves. After standing, for twenty-four hours, the product is separated by filtration. On crystallization from carbon tetrachloride, the product, trans-1-carbethoxy-4-carbamy1-2,5-dimethylpiperazine, melting at 118.5- 119.5 0., is obtained.
The intermediate, trans-1-carbethoxy-2,5-dimethylpiperazine, may be prepared from ethyl chlorocarbonate and trans2,5dimethylpiperazine by the method described by Moore, Boyle and Thorn, Journal of the Chemical Society, 39 (1929). It distills at 112 at 10 mm.
[Example 5] [To a solution of 56 parts of trans-1-carbethoxy-2,5-dimethylpiperazine in 210 parts of absolute ether is added anhydrous hydrogen chloride until the reaction mixture is acidic to Congo red paper. The hydrochloride salt obtained is isolated by filtration, ground and mixed well with the evolution of methyl mercaptan ceases.
32 parts of potassium thiocyanate. The mixture is then heated at 130 0. for five minutes. The reaction becomes slightly exothermic at about 110 C. After cooling, the reaction product is slurried in boiling isopropyl acetate, the potassium chloride is removed by filtration and the filtrate is diluted with petroleum ether. On cooling, trans-1-c'arbethoxy-2,5-dimethyl-4-thiocarbamylpiperazine is obtained which has a meltin point of 94.505 0.]
Example 6 To a solution of 78 parts of ethyl alcohol in parts of Water are added 41.8 parts of S- methylisothiourea sulfate and 56 parts of trans- 1-carbethoxy-2,5dimethylpiperazine. The reaction mixture is refluxed on a steam bath until The reaction mixture is dehydrated by azeotropic distillation with benzene. The resulting solid, trans- 1-carbethoxy-2,5-dimethyl 4 guanylpiperazine sulfate, may be further purified by crystallization in the usual manner.
Example 7 N N H N-00Oalky1 wherein R and R are members of the group consisting of hydrogen and lower alkyl radicals, R and R are members of the group consisting of hydrogen and alkyl radicals, and X is a member of the group consisting of oxygen, sulfur and imino radicals, and R" and R' are not simultaneously hydrogen when X is sulfur.
2. A l-carbalkoxypiperazine having the general formula:
wherein R" and R' are members of the group consisting of hydrogen and alkyl radicals, and X is a member of the group consisting of oxygen, sulfur and imino radicals, and R and R are not simultaneously hydrogen when X is sulfur.
3. A 1-carbalkoxy-4=-dialkylthiocarbamylpiperazine having the general formula:
in which R" and R are alkyl radicals.
[4. The compound 1-carbethoxy-4-thiocarbamylpiperazine having the following formula:
s ll
5 5. The compound 1-carbethoxy-2,5-dimethyl- 4-guanylpiperazine having the following formula:
6. The compound 1-carbethoxy-4-diethy1carbamylpiperazine having the following formula:
\NC- H N-OO0C2H5 C7115 RICHARD JOSEPH TURNER. HUGH WENDELL STEWART.
References Cited in the file of this patent or the original patent UNITED STATES PATENTS 5 Number Name Date Buck Feb. 11, 1947 Buck Feb. 11, 1947 Kushner Apr. 19, 1949 Kushner Apr. 19, 1949 Kushner Apr. 19, 1949 Steward June 7, 1949
Publications (1)
Publication Number | Publication Date |
---|---|
USRE23702E true USRE23702E (en) | 1953-08-18 |
Family
ID=2091228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US23702D Expired USRE23702E (en) | L-carbalkoxy-x-substituted |
Country Status (1)
Country | Link |
---|---|
US (1) | USRE23702E (en) |
-
0
- US US23702D patent/USRE23702E/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2595334A (en) | Benzothiazolesulfonamides and method of preparing the same | |
Thirtle | 2-Mercaptopyridine | |
DE1945542A1 (en) | Process for the preparation of 4-heterosubstituted azetidinones- (2) | |
DE949105C (en) | Process for the production of new, fungicidal and protozoocidal aromatic aminoketones and their salts | |
US4480103A (en) | 4-Fluoro-5-oxypyrazole derivatives | |
USRE23702E (en) | L-carbalkoxy-x-substituted | |
US2535971A (en) | 1-carbalkoxy-4-substituted piperazines | |
CH500223A (en) | Subst. 4,5-dihydro-1,3-dimethyl-1H-pyrazolo-(3,4-b)(1,4)-benzoxazepines and pyrazolo-(3,4-b)(1,4)-benzothiazepines (I) :- X = O, S, SO2 Y = CO, CH2 | |
DE2124907A1 (en) | 3 Amino 1,2,4 oxadiazoles, process for their preparation and medicinal preparations | |
US2540946A (en) | Pyridoxal-histamine and processes for preparing the same | |
US3060192A (en) | Production of enantiomers of alphamethyl-phenethyl hydrazine and intermediate | |
DE946804C (en) | Process for the production of sulfur-containing extracts of barbituric acid | |
US3133933A (en) | Certain | |
US2524802A (en) | Hydroxybenzenesulfonamidopyridazines and preparation of same | |
CH637951A5 (en) | 3-PYRAZOL-1-YL-PYRIDAZINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL PREPARATIONS CONTAINING THESE COMPOUNDS. | |
USRE23701E (en) | Substituted piperazines and method | |
US2554186A (en) | Para-amino hydroxybenzamides | |
EP0001982B1 (en) | Process for preparing aromatic aminohydroxy compounds | |
DE832891C (en) | Process for the preparation of thiosemicarbazides | |
US4118501A (en) | Thiazolidine derivatives | |
DE839349C (en) | Process for the preparation of thiosemicarbazides | |
US4156735A (en) | Thiazolidine derivatives | |
DE2823712C2 (en) | Process for the preparation of pleuromutilin derivatives | |
AT238212B (en) | Process for the preparation of new 3-aryl-4-halogen-pyridazonen- (6) | |
US2030373A (en) | Derivatives of thiazole and process of preparing the same |